ArticleJournal of translational medicine2026
ABCC2 as a novel therapeutic target in lung adenocarcinoma: a machine learning-driven discovery linking ammonia metabolism to prognosis and drug resistance.
Shuangqing Liao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.